Table 3

Risk of first subsequent major adverse outcome for women compared with men (reference category)

Cox model
HR (95% CI)
Competing risks model*
Sub-HR (95% CI)
Model 1†
Major adverse cardiovascular event0.68 (0.67 to 0.69)0.71 (0.70 to 0.72)
 Coronary heart disease0.62 (0.61 to 0.63)0.64 (0.63 to 0.65)
 Stroke1.25 (1.18 to 1.32)1.33 (1.26 to 1.41)
 Peripheral vascular disease0.92 (0.83 to 1.02)0.95 (0.86 to 1.06)
 Heart failure1.04 (1.00 to 1.09)1.09 (1.04 to 1.14)
 Cardiovascular-related death0.94 (0.90 to 0.98)0.99 (0.95 to 1.03)
All-cause mortality0.96 (0.94 to 0.98)1.02 (1.00 to 1.05)
Model 2‡
Major adverse cardiovascular event0.67 (0.66 to 0.68)0.69 (0.68 to 0.70)
 Coronary heart disease0.60 (0.59 to 0.61)0.62 (0.61 to 0.63)
 Stroke1.26 (1.19 to 1.33)1.32 (1.25 to 1.39)
 Peripheral vascular disease0.92 (0.83 to 1.02)0.95 (0.85 to 1.05)
 Heart failure1.09 (1.04 to 1.15)1.13 (1.07 to 1.18)
 Cardiovascular-related death0.99 (0.95 to 1.03)1.02 (0.98 to 1.06)
All-cause mortality1.05 (1.02 to 1.07)1.11 (1.08 to 1.13)
  • *Fine and Gray method for subdistribution regression with competing risks.22

  • †Model 1: adjusted for age (continuous variable).

  • ‡Model 2: adjusted for age (continuous variable), socioeconomic status, smoking status, body mass index, blood pressure, total cholesterol level, history of alcohol problem, diabetes mellitus, dyslipidaemia, cancer, chronic kidney disease, hypertension, atrial fibrillation, depression and a family history of cardiovascular disease.